韩国上部胃肠子亚皮质病变的流行,自然进展和临床实践:一项多中心研究
Younghee Choe1, Yu Kyung Cho1,2, Gwang Ha Kim3,2
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Clinical endoscopy
|August 25, 2023
概括
上部胃肠道亚皮质病变 (UGI SELs) 的患病率为1.60%. 超过1厘米的胃SEL显示出23%的癌前率,通常通过内镜超声波 (EUS) 和临床决定进行管理.
科学领域:
- 胃肠病学 胃肠病学
- 内镜检查是指内镜检查.
- 在瘤学瘤学.
背景情况:
- 亚皮质病变 (SEL) 是胃肠道上部 (UGI) 系统的常见发现.
- 了解它们的患病率和自然进展对于患者管理至关重要.
研究的目的:
- 评估UGI SELs的流行率和自然进展情况.
- 评估这些病变的特征和治疗方法.
主要方法:
- 八所大学医院的医疗记录的回顾性分析 (2010年1月至12月).
- 直到2016年12月进行的后续评估.
- 包括65233名接受查的参与者,他们有UGI SEL.
主要成果:
- UGI SEL 的内镜流行率为1.60% (1,044/65,233).
- 最常见的病变是乳腺瘤,胃肠道 stromal 瘤 (GIST) 和宫外胰腺,主要在胃部 (63.8%).
- 恶性潜力随大小增加:3% (<1厘米) 到38% (≥3厘米);23%的胃SEL≥1厘米是癌前的,在切除生长病变后发现了12个GIST.
结论:
- UGI SEL 的流行率为 1.60%.
- 胃SEL≥1厘米的显著比例 (23%) 是癌前的.
- 管理通常涉及内镜超声波 (EUS) 和临床决策,没有立即的病理确认.
相关概念视频
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
155
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
155
Peptic Ulcer Disease II: Pathophysiology
518
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
518
Barrett Esophagus-I: Introduction
123
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
123
Barrett Esophagus-II: Clinical Manifestations and Management
192
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
192
Peptic Ulcer Disease I: Introduction
197
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
197
Gastritis III: Clinical Manifestations and Management
322
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
322


